BEENA RAJAGOPAL: Open Payments
NPI 1700335791 · NASHUA, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,700 in 169 payments from 19 companies in 2025. Trend: 2023 $334 · 2024 $1,891 · 2025 $3,700
Food & beverage: $3,621Education: $79
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 21 | $572 |
| Takeda Pharmaceuticals U.S.A., Inc. | 26 | $569 |
| ABBVIE INC. | 33 | $557 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 23 | $398 |
| Gilead Sciences, Inc. | 15 | $381 |
| PFIZER INC. | 14 | $270 |
| Regeneron Healthcare Solutions, Inc. | 7 | $156 |
| Lilly USA, LLC | 5 | $119 |
| GENZYME CORPORATION | 4 | $113 |
| Ardelyx, Inc. | 6 | $100 |
Products named: TREMFYA, ENTYVIO, XIFAXAN, DUPIXENT, RINVOQ, XELJANZ, OMVOH, SKYRIZI.
Industry payments across NH — which companies pay providers there.
